// STATE LEGISLATION TRACKER

Missouri SB 108: Repeals provisions of law relating to abortion

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Missouri
Bill: SB 108
Filed: 2022-12-01
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Missouri SB 108 appears to be an abortion-related bill, described as repealing provisions of Missouri law relating to abortion. Based on the title, subject, and available status only, it does not appear to regulate compounded peptides, off-label prescribing, telehealth peptide care, clinician scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No apparent direct effect on peptide prescribing or access
No visible changes to compounding pharmacy rules
No apparent change to NP or naturopathic peptide scope
No visible telehealth or prescription-monitoring provisions

What to Watch For

Note If full bill text is reviewed later, check for any broad drug, pharmacy, or clinician language hidden in repealed sections.

Note Abortion-related reproductive health rules may affect some clinicians, but no peptide-specific impact is apparent.

Where the Bill Stands

SB 108 was referred to the Senate Health and Welfare Committee on January 19, 2023, and the 2023 session ended without passage.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws